Erste Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.89M | Buy |
|
|||||
|
2022
Q4 | $1.62M | Buy |
|
|||||
|
2022
Q3 | $1.98M | Hold |
|
|||||
|
2022
Q2 | $2.57M | Buy |
|
|||||
|
2022
Q1 | $5.23M | Buy |
|
|||||
|
2021
Q4 | $5.92M | Sell |
|
|||||
|
2021
Q3 | $5.79M | Buy |
|
|||||
|
2021
Q2 | $4.47M | Buy |
|
|||||
|
2021
Q1 | $6.49M | Buy |
|
|||||
|
2020
Q4 | $3.9M | Hold |
|
|||||
|
2020
Q3 | $4.77M | Buy |
|
|||||
|
2020
Q2 | $3.83M | Sell |
|
|||||
|
2020
Q1 | $2.87M | Sell |
|
|||||
|
2019
Q4 | $5.47M | Buy |
|
|||||
|
2019
Q3 | $2.11M | Buy |
|
|||||
|
2019
Q2 | $3M | Buy |
|
|||||
|
2019
Q1 | $3.52M | Buy |
|
|||||
|
2018
Q4 | $1.04M | Buy |
|